Robert Debernardo

Loss of cables, a cyclin-dependent kinase regulatory protein, is associated with the development of endometrial hyperplasia and endometrial cancer.

Defining the extent of cables loss in endometrial cancer subtypes and its effectiveness as an inhibitor of cell proliferation in malignant endometrial cells in vitro and in vivo.

Low-molecular-weight heparin (dalteparin) in women with gynecologic malignancy.

Abnormal activation and cytokine spectra in lymph nodes of people chronically infected with HIV-1.

Adjuvant treatment and survival in obese women with endometrial cancer: an international collaborative study.

Surgical management of malignant bowel obstruction: strategies toward palliation of patients with advanced cancer.

Stereotactic body radiosurgery for pelvic relapse of gynecologic malignancies.

Sunitinib malate in the treatment of recurrent or persistent uterine leiomyosarcoma: a Gynecologic Oncology Group phase II study.

A double-blind, randomized trial of pyridoxine versus placebo for the prevention of pegylated liposomal doxorubicin-related hand-foot syndrome in gynecologic oncology patients.

A phase II study of two topotecan regimens evaluated in recurrent platinum-sensitive ovarian, fallopian tube or primary peritoneal cancer: a Gynecologic Oncology Group Study (GOG 146Q).

Phase I feasibility study of intraperitoneal cisplatin and intravenous paclitaxel followed by intraperitoneal paclitaxel in untreated ovarian, fallopian tube, and primary peritoneal carcinoma: a gynecologic oncology group study.

Chemotherapy plus radiation in advanced-stage endometrial cancer.

Endometrial stromal sarcoma metastasis to the lumbar spine and sphenoid bone.

Robotic surgery in gynecologic oncology.